BBSRC Portfolio Analyser
Award details
Combinatorial bioformulation of epidermal growth factors
Reference
BB/C50466X/1
Principal Investigator / Supervisor
Dr Ana Maria Gonzalez
Co-Investigators /
Co-Supervisors
Professor Andrew Baird
,
Professor Martin Berry
,
Professor Margaret Lawrence
,
Professor Ann Logan
Institution
University of Birmingham
Department
Medical Sciences - Medicine
Funding type
Research
Value (£)
217,842
Status
Completed
Type
Research Grant
Start date
01/01/2005
End date
31/08/2008
Duration
44 months
Abstract
Biopharmaceutical drug development is hampered by an inability to formulate proteins to enter the brain. Unlike small molecule drugs, biopharmaceuticals (e.g. antibodies, peptides and proteins) cannot be modified by rational design without having a profound - and often unexpected - effects on their biological activity. A multidisciplinary group of 5 co-applicants will apply a technique called Combinatorial Bioformulation to (1) identify peptide-chimera or epidermal growth factor (EGF) that translocate from blood into the CNS, (2) characterise their effects on CNS function and (3) establish a structural basis for their activity because EGF can stimulate stem cells, glia and neurons but only when it is introduced directly into the CNS.
Summary
unavailable
Committee
Closed Committee - Engineering & Biological Systems (EBS)
Research Topics
Neuroscience and Behaviour, Pharmaceuticals
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search